Related Experiment Videos
Predicting tuberculosis treatment outcome in a low-incidence area
I Baussano1, E Pivetta, L Vizzini
1Division of Epidemiology, Public Health and Primary Care, Imperial College, London, UK. i.baussano06@imperial.ac.uk
Summary
This study identified key factors influencing the success of pulmonary tuberculosis (PTB) treatment in Italy. A nomogram was developed to predict unfavorable outcomes, aiding in targeted patient follow-up for better case management.
Area of Science:
- Public Health
- Epidemiology
- Infectious Diseases
Background:
- Pulmonary tuberculosis (PTB) remains a significant global health challenge.
- Standardized short-course chemotherapy (SSCC) is the primary treatment modality for PTB.
- Identifying predictors of treatment success is crucial for optimizing patient outcomes and resource allocation.
Purpose of the Study:
- To determine factors associated with unsuccessful PTB treatment outcomes.
- To develop a predictive nomogram for identifying PTB cases requiring intensified follow-up.
- To support clinicians and public health officials in managing PTB effectively.
Main Methods:
- Retrospective cohort study of pulmonary tuberculosis cases in the Piedmont region, Italy (2001-2005).
- Analysis of demographic, geographic, and treatment-related factors influencing SSCC success.
- Development of a nomogram based on identified predictors of treatment outcome.
Main Results:
- 1564 PTB cases were analyzed.
- Predictors of successful treatment included female sex, EU geographic origin, and outpatient treatment.
- Predictors of unsuccessful treatment included homeless status and increasing age.
Conclusions:
- A nomogram effectively predicts individual probability of unfavorable SSCC outcomes using select predictors.
- This predictive tool can be generalized and calibrated for local PTB case management.
- The nomogram facilitates targeted follow-up strategies to improve PTB treatment success rates.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...